Cincinnati Children’s Hospital Medical Center began construction in June of 2024 on the Applied Gene and Cell Therapy Center in Sharonville, Ohio. The $60 million project will transform an existing structure into a catalyst for innovative clinical trials. Designed by BHDP Architecture, the 111,000-sf facility will advance the development, testing, and manufacture of new medicines and biological therapies.
Sanofi opened a 20,000-sf biomanufacturing center in May of 2024 in Toronto. Producing adult and pediatric vaccines for pertussis, diphtheria, and tetanus, the project significantly increases capacity to meet growing demand in Canada and around the world. The next-generation facility features advanced bioprocessing suites supported by highly efficient infrastructure. Commissioning is currently under way, with full operations slated to commence in mid-2025.
Columbia University broke ground in late May of 2024 on the first all-electric biomedical research building in New York City. Designed by KPF, the 77,000-sf facility will drive innovation in genetic and genomic science to create new treatments for some of the most significant threats to human health today. The eight-story structure will feature state-of-the-art laboratories linked by "collaboration corners" with welcoming lounges for informal interaction and exchange.
AstraZeneca is planning to construct a US$1.5 billion facility in Singapore for the manufacture of antibody drug conjugates (ADCs). Enabling the creation of precision cancer therapies, the project will integrate every stage of the ADC production process at commercial scale. The sustainably designed building is slated to achieve net-zero operational carbon and will leverage advanced infrastructure to achieve optimal energy performance. Completion is expected in 2029. A site for the greenfield development has yet to be determined.
North Carolina State University is constructing the $180 million Integrative Sciences Building in Raleigh. Designed by ZGF Architects and Moseley Architects, the 164,947-sf facility will provide leading-edge environments for programs in chemistry, biochemistry, and the biological sciences. The collaborative five-story structure will offer two floors of teaching labs, as well as an advanced research floor integrating physical and life sciences in a way not possible anywhere else on campus.
Michigan State University (MSU) and Henry Ford Health have joined forces to construct the $335 million Henry Ford Health + Michigan State University Research Center, which will house 84 principal investigators and their research teams focused on cancer, neuroscience, infectious diseases, immunology, and public health. The first floor will accommodate a large core lab including an imaging suite. An entire floor will be dedicated to the Nick Gilbert Neurofibromatosis Research Institute.
Construction has begun on the Marine Research Institute and Sea Turtle Research Center and Hospital at the University of Florida’s Whitney Lab for Marine Bioscience. The building, designed by Lord Aeck Sargent and TTV Architects, is planned for LEED Gold certification. DPR is the construction manager.
Merck celebrated the beginning of construction for the $325 million Advanced Research Center in April of 2024. Located on the company's Darmstadt headquarters campus in Germany, the biopharmaceutical innovation facility will accelerate the development of novel processes and materials for the production of antibodies, recombinant proteins, and viral vectors. The flexible structure will also drive advances in pharmaceutical purification, formulation, and analytical chromatography.
Wexford Science + Technology is constructing the $1.2 billion Aggie Square on the Sacramento campus of the University of California, Davis. Designed by ZGF Architects, the innovation district is being developed in association with GMH Capital Partners. The 8.25-acre site will feature an expansive plaza framed by three glass-clad structures providing between 230,000 sf and 310,000 sf each.
Michigan Tech opened the H-STEM Engineering and Health Technologies Complex in Houghton in March of 2024. HED designed the collaborative facility to drive academic excellence in health-related fields and accelerate the creation of human-centered technological innovations. Positioned in the heart of campus, the development collocates researchers in materials science, engineering, and neuroscience with faculty from kinesiology and integrative physiology.
The International Society for Pharmaceutical Engineering (ISPE) has announced the 2024 Facility of the Year Awards category winners. The awards include:
The University of Delaware broke ground in April of 2024 on the Securing American Biomanufacturing Research and Education (SABRE) Center. The $150 million facility will enhance the R&D capabilities of the adjacent National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) while driving the creation of a skilled workforce. Serving as a living laboratory for the formulation of best practices, the 70,000-sf building is envisioned as a place to scale up and mature new production methods.
Delancey is planning to construct a £400 million innovation hub in London's Knowledge Quarter. Designed by Gardiner & Theobald and KPF, the 194,000-sf structure will offer 130,000 sf of leasable research space for biomedical companies, technology firms, and start-up enterprises. The highly adaptable facility will feature next-generation laboratories, traditional and open offices, a maker space, and a community event venue. Typical floors will have access to an amenity terrace with a range of interactive settings.
Carnegie Mellon University broke ground in early 2024 on the $252 million Richard King Mellon Hall of Sciences in Pittsburgh. Designed by ZGF Architects and R3A Architecture, the 338,900-sf complex will advance a new era of data-driven research, cross-disciplinary education, and creative expression. The transformative development will collocate the College of Science and the School of Computer Science with the Institute for Contemporary Art Pittsburgh in a prominent city intersection to foster connections with the local community.
FUJIFILM Diosynth Biotechnologies is constructing a $3.2 billion pharmaceutical campus in Holly Springs, N.C. Integrating sophisticated automation technologies, the multi-building development will enable large-scale cell culture manufacturing for the creation of bulk drug substances. Ground was broken in October of 2021 on the first phase, a $2 billion production center slated for completion in early 2025. A subsequent investment of $1.2 billion will establish an additional 425,000-sf plant that will begin operations in 2028.
